Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)

Autor:	Yosuke Takamiya, Keisuke Okamura, Kazuyuki Shirai, Tetsu Okuda, Kunihisa Kobayashi, Hidenori Urata
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	teneligliptin dipeptidyl peptidase-4 inhibitor glycemic control hypotensive effect safety Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Clinical and Experimental Hypertension, Vol 42, Iss 3, Pp 197-204 (2020)
Druh dokumentu:	article
ISSN:	1064-1963 1525-6006 10641963
DOI:	10.1080/10641963.2019.1601207
Popis:	Objective: We purpose to confirm the effect of teneligliptin (Tenelia), a selective dipeptidyl peptidase-4 (DPP-4) inhibitor, on glycemic control and non-glucose risk factors for macroangiopathy, including blood pressure, lipid metabolism, and body weight. Methods: In a prospective, multicenter, open-label, observational study, teneligliptin (20 mg/day) was administered to type 2 diabetic patients with poor glycemic control (HbA1c ≥ 6.5% to
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/dc5d542dfb4c4a4689dc9a1a46eae9c1 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.